Under our open innovation framework SBC has a team of industry lead experts – DA – who represent our early engagement with academia throughout the UK, offering simple, unbiased and in the main free advice. Co-ordinated by myself, Nuno Alves and chaired by Professor Bill Dawson, the team have many years of relevant industry experience and can guide researchers all the way from discovery to development of new compounds, small molecules, biologics and medical devices. Our expertise covers a wide range of therapeutic areas and technology platforms, including but not exclusive to SBCs strategic focus areas of small molecule drug discovery, cell therapies and technologies, neurosciences, antibody technologies, biomarkers and convergent medical technologies.
For many of you who have already met us you will know a little about what we do and our team. However we are always keen to hear from new groups who have exciting and innovative research, which may benefit from a helping expert hand. You can learn much more about us on our webpages within the catalyst innovation portal and we would be delighted to hear from you (contact me directly on Nuno.email@example.com)